Viewing data from:

AGGRENOX

NDA

ASPIRIN; DIPYRIDAMOLE | N020884 | BOEHRINGER INGELHEIM PHARMACEUTICALS INC

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

1 case on OB patents from PACER

Case	Court	Filed	Status	Judge
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. AMNEAL PHARMACEUTICALS LLC 1:2014cv04726 1 patentANDA 206392dipyridamole and acetylsalicylic acid	D.N.J.	2014-07-30	Terminated 2015-01-26	—

Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

Approval Letters

11 letters from Drugs@FDA

Source: Drugs@FDA application documents.

Products (1)

#001 — 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RLD

0 patents0 exclusivities▴

CAPSULE, EXTENDED RELEASE;ORAL | Approved: Nov 22, 1999

No patent or exclusivity listings for this strength.